Towards Risk Stratification in Clinical Care for IgA Nephropathy: Genetic Risk Scores: Comments on the Study "Clinical Application of Polygenic Risk Score in IgA Nephropathy"
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Sinnott-Armstrong N, Tanigawa Y, Amar D, Mars N, Benner C, Aguirre M
. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nat Genet. 2021; 53(2):185-194.
PMC: 7867639.
DOI: 10.1038/s41588-020-00757-z.
View
2.
Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M
. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014; 46(11):1187-96.
PMC: 4213311.
DOI: 10.1038/ng.3118.
View
3.
Barbour S, Canney M, Coppo R, Zhang H, Liu Z, Suzuki Y
. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool. Kidney Int. 2020; 98(4):1009-1019.
DOI: 10.1016/j.kint.2020.04.042.
View
4.
Holscher D, Bouteldja N, Joodaki M, Russo M, Lan Y, Vafaei Sadr A
. Next-Generation Morphometry for pathomics-data mining in histopathology. Nat Commun. 2023; 14(1):470.
PMC: 9884209.
DOI: 10.1038/s41467-023-36173-0.
View
5.
Feehally J, Farrall M, Boland A, Gale D, Gut I, Heath S
. HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol. 2010; 21(10):1791-7.
PMC: 3013538.
DOI: 10.1681/ASN.2010010076.
View